FI61688C - Foerfarande foer framstaellning av terapeutiskt anvaendbara oxminsyraderivat - Google Patents
Foerfarande foer framstaellning av terapeutiskt anvaendbara oxminsyraderivat Download PDFInfo
- Publication number
- FI61688C FI61688C FI662/74A FI66274A FI61688C FI 61688 C FI61688 C FI 61688C FI 662/74 A FI662/74 A FI 662/74A FI 66274 A FI66274 A FI 66274A FI 61688 C FI61688 C FI 61688C
- Authority
- FI
- Finland
- Prior art keywords
- mol
- give
- found
- title compound
- condensed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/02—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
- C07C245/06—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
- C07C245/08—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/14—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D241/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/38—Nitrogen atoms
- C07D277/44—Acylated amino or imino radicals
- C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US34446673A | 1973-03-23 | 1973-03-23 | |
| US34446673 | 1973-03-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI61688B FI61688B (fi) | 1982-05-31 |
| FI61688C true FI61688C (fi) | 1982-09-10 |
Family
ID=23350656
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI662/74A FI61688C (fi) | 1973-03-23 | 1974-03-06 | Foerfarande foer framstaellning av terapeutiskt anvaendbara oxminsyraderivat |
Country Status (14)
| Country | Link |
|---|---|
| JP (1) | JPS5920664B2 (ja) |
| AR (1) | AR207563A1 (ja) |
| BE (1) | BE812743A (ja) |
| CA (1) | CA1034118A (ja) |
| CH (1) | CH612914A5 (ja) |
| DE (1) | DE2413966A1 (ja) |
| EG (1) | EG11281A (ja) |
| ES (1) | ES424514A1 (ja) |
| FI (1) | FI61688C (ja) |
| FR (1) | FR2222097B1 (ja) |
| NL (1) | NL7403843A (ja) |
| PH (1) | PH14870A (ja) |
| SE (1) | SE411898B (ja) |
| ZA (1) | ZA74635B (ja) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4011337A (en) * | 1975-07-07 | 1977-03-08 | The Upjohn Company | Oxamide-oxamic compounds, compositions and methods of use |
| US4172147A (en) * | 1976-11-17 | 1979-10-23 | The Upjohn Company | 3,5-Dinitro oxanilic acid ester compounds, compositions and methods |
| US4119783A (en) * | 1977-02-18 | 1978-10-10 | The Upjohn Company | 3'Lower alkylcarbonyl oxanilic acid esters |
| NL7810634A (nl) * | 1977-10-28 | 1979-05-02 | May & Baker Ltd | Tetrazool-derivaten. |
| DE3027527A1 (de) | 1980-07-19 | 1982-02-18 | Basf Ag, 6700 Ludwigshafen | Neue oxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel |
| DE3027528A1 (de) * | 1980-07-19 | 1982-02-18 | Basf Ag, 6700 Ludwigshafen | Ueberbrueckte thiazolyloxamidsaeure-derivate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel |
| DE3135250A1 (de) * | 1981-09-05 | 1983-03-17 | Basf Ag, 6700 Ludwigshafen | Tricyclische thiazolyloxamate, verfahren zu ihrer herstellung und diese enthaltende therapeutische mittel |
| FR2546885B1 (fr) * | 1983-06-06 | 1986-02-07 | Fabre Sa Pierre | Oxamates d'anthranilates fonctionnalises utiles comme medicaments dans le traitement des dermatoses inflammatoires |
| JPS6112268U (ja) * | 1984-06-25 | 1986-01-24 | 松下電工株式会社 | プリント配線基板 |
| JPH072697B2 (ja) * | 1985-05-24 | 1995-01-18 | 久光製薬株式会社 | 新規なオキサニル酸誘導体 |
| US6225329B1 (en) | 1998-03-12 | 2001-05-01 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (PTPases) |
| AU2713699A (en) * | 1998-03-12 | 1999-09-27 | Novo Nordisk A/S | Modulators of protein tyrosine phosphatases (ptpases) |
| ES2395682T3 (es) | 2007-08-20 | 2013-02-14 | Symrise Ag | Derivados de ácido oxálico y su uso como principios activos refrescantes fisiológicos |
-
1974
- 1974-01-01 AR AR252822A patent/AR207563A1/es active
- 1974-01-30 ZA ZA00740635A patent/ZA74635B/xx unknown
- 1974-03-04 PH PH15573A patent/PH14870A/en unknown
- 1974-03-06 FI FI662/74A patent/FI61688C/fi active
- 1974-03-20 EG EG86/74A patent/EG11281A/xx active
- 1974-03-21 NL NL7403843A patent/NL7403843A/xx not_active Application Discontinuation
- 1974-03-22 ES ES424514A patent/ES424514A1/es not_active Expired
- 1974-03-22 DE DE2413966A patent/DE2413966A1/de not_active Ceased
- 1974-03-22 FR FR7409903A patent/FR2222097B1/fr not_active Expired
- 1974-03-22 SE SE7403941A patent/SE411898B/xx unknown
- 1974-03-22 CH CH405374A patent/CH612914A5/xx not_active IP Right Cessation
- 1974-03-22 CA CA195,729A patent/CA1034118A/en not_active Expired
- 1974-03-22 BE BE142383A patent/BE812743A/xx not_active IP Right Cessation
- 1974-03-23 JP JP49033104A patent/JPS5920664B2/ja not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| CA1034118A (en) | 1978-07-04 |
| FR2222097B1 (ja) | 1978-06-30 |
| AR207563A1 (es) | 1976-10-15 |
| ZA74635B (en) | 1975-09-24 |
| JPS5920664B2 (ja) | 1984-05-15 |
| JPS49135929A (ja) | 1974-12-27 |
| BE812743A (fr) | 1974-09-23 |
| FR2222097A1 (ja) | 1974-10-18 |
| CH612914A5 (en) | 1979-08-31 |
| FI61688B (fi) | 1982-05-31 |
| DE2413966A1 (de) | 1974-09-26 |
| AU6575374A (en) | 1975-08-21 |
| NL7403843A (ja) | 1974-09-25 |
| PH14870A (en) | 1982-01-08 |
| SE411898B (sv) | 1980-02-11 |
| ES424514A1 (es) | 1976-06-16 |
| EG11281A (en) | 1977-05-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US3966965A (en) | Oxamic acid derivatives for the prevention of immediate type hypersensitivity reactions | |
| FI61688C (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara oxminsyraderivat | |
| US4069343A (en) | Oxamic acid derivatives for the prevention of immediate type hypersensitivity reactions | |
| US4057632A (en) | Method of treatment using tetrazole-5-carboxamide derivatives | |
| US4036837A (en) | 2 Alkoxyoxamoyl-pyrazines | |
| US4054666A (en) | Compositions and methods of treating immediate hypersensitivity reactions with thiazolyl oxamic acid derivatives | |
| US4110453A (en) | N-(2-pyrimidinyl)1h-(or 2h)tetrazole-5-carboxamide derivatives for the prevention of immediate type hypersensitivity reactions | |
| JPS5946220B2 (ja) | 複素環化合物の製法 | |
| US4044144A (en) | 1H-tetrazole-5-carboxamides | |
| US4082751A (en) | Therapeutic agents | |
| US4096153A (en) | Arylene-bis-tetrazole-5-carboxamides | |
| US4160100A (en) | Oxamic acid derivatives | |
| US4191840A (en) | Oxamic acid derivatives | |
| US4154961A (en) | Oxamic acid derivatives | |
| US3937719A (en) | (4-oxo-4h-1-benzopyran-2-yl)-oxamic acid, salts and esters anti-allergic agents | |
| CA1071203A (en) | Aromatic amidines as antiviral agents in animals | |
| US4625028A (en) | 6-aryluracils and selected novel intermediates used in the preparation thereof | |
| US4110458A (en) | N-(pyridyl) oxamic acid derivatives | |
| US4171367A (en) | Pyrazolyl amino imidazolines | |
| US4054657A (en) | Pyrimidinyl oxamic acids and esters, and compositions and methods for the suppression of allergic manifestations | |
| EP0064385B1 (en) | 2,6-diaryl-pyridinecarboxylic acids and their therapeutic utility | |
| US4054661A (en) | Pyridyl oxamic acid derivatives and use in the prevention of allergic reactions | |
| US4087606A (en) | 2-Cyano-3- or 4-(substituted amino)oxanilic acid derivatives | |
| US4032652A (en) | Substituted 2h-pyran-2,6(3h)-dione derivatives, pharmaceutical compositions comprising such derivatives and methods of inhibiting the antigen-antibody reaction | |
| US3989835A (en) | Method of using 6-substituted amino phenyl-2,3,5,6-tetra-hydro[2,1-b]thiazoles for controlling gastrointestinal nematodes |